Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Blaasstoornis bij MS behandelen met neuromodulatie
mei 2024 | Multipele Sclerose